PO.IM03.01 · 免疫学

HIV 相关克隆性造血中的异常 T 细胞增殖

Aberrant T cell proliferation in HIV associated clonal hematopoiesis

海报缩略图:HIV 相关克隆性造血中的异常 T 细胞增殖
编号 222 展板 17 时间 4/19 02:00–05:00 区域 Section 10 主讲 Haocong (Katherine) Ma, B Eng;MS
分会场 Virology and Cancer
查看 PDF 下载 PDF 🔒 查看 / 下载完整 PDF 需登录并开通下载套餐 · 查看套餐 / 开通 AACR 官方页面

作者与单位 Authors & Affiliations

Haocong Katherine Ma1, Tsung-Chih Chen1, Alokkumar Jha2, Benjamin A. Youngblood3, Jennifer M. Kwan1, Irini Sereti4, Ya-Chi Ho1

1Yale School of Medicine, New Haven, CT,2Weill Cornell Medicine, New York, NY,3St. Jude Children's Research Hospital, Memphia, TN,4National Institutes of Health, Bethesda, MD

摘要 Abstract

中文摘要
引言:克隆性造血(CH)是急性髓系白血病(AML)的前驱状态,也是血液系统癌症发生的预测因素。尽管接受抑制性抗逆转录病毒治疗,HIV 感染者(PLWH)仍具有更高的克隆性造血发生率,尤其是 DNMT3A 突变。虽然 DNMT3A 突变会增加髓系细胞中的炎症并增加 CD8+ T 细胞增殖,但 DNMT3A 突变在 CD4+ T 细胞中的作用仍不明确。鉴于 CD4+ T 细胞是主要的 HIV 储存库,我们推测 HIV 诱导的全身性炎症会增加 DNMT3A 突变,加速 CD4+ T 细胞增殖,从而促进 HIV 在 CD4+ T 细胞中的持续存在。 方法:为研究 DNMT3A 对 CD4+ T 细胞增殖的影响,我们在单细胞 ECCITE-seq(GoT-seq)中掺入 HIV 和 DNMT3A 特异性引物,并对来自四个分层(HIV+CH+、HIV+CH-、HIV-CH+ 和 HIV-CH-)的外周血 CD4+ T 细胞进行配对的 HIV 和 DNMT3A 靶向长读长测序(MAS-ISO-Seq)。我们在同一单细胞中同时捕获 HIV RNA、细胞转录组、表面蛋白、T 细胞克隆性和 DNMT3A 突变。 结果:经质控后,我们从 27 名参与者(7 名 HIV+CH+、7 名 HIV+CH-、5 名 HIV-CH+ 和 8 名 HIV-CH-)中捕获了 420,837 个 CD4+ T 细胞。短读长 scRNA-seq 在 32,554 个细胞(10.3%)中检测到 DNMT3A RNA,而长读长测序在 19,898 个细胞(8.6%)中捕获到 DNMT3A,反映出外周血 CD4+ T 细胞中 DNMT3A 表达水平较低。重要的是,我们克服了短读长测序的 5' 测序偏倚,捕获了 767 个在 DNMT3A 内携带单核苷酸多态性(SNP)的细胞。对于 HIV,短读长鉴定出 170 个 RNA+ 细胞(0.055%),而长读长检测到 3,842 个 HIV 感染细胞,敏感性提高了 22 倍,并解析出 98 个完整的前病毒。TCR 分析从 76,819 个具有已比对 CDR3 区的细胞中重建了 22,648 个独特的 T 细胞克隆。较大的 CD4+ T 细胞克隆富集于高表达 GZMB/GZMH 的细胞毒性 CD4+ T 细胞中。值得注意的是,我们在 T 细胞克隆中鉴定出 100 个 HIV 感染细胞(58.8%)。HIV-CH+ 供者的 CD4+ T 细胞克隆大小大于 HIV-CH- 供者,与 CH 驱动的 T 细胞增殖一致。重要的是,HIV+CH+ 患者的 CD4+ T 细胞相比 HIV+CH- 患者表现出显著更大的克隆扩增和更大的克隆,提示 CH 突变也促进 HIV 感染细胞的增殖。值得注意的是,各组间年龄分布无差异,排除了年龄作为克隆扩增混杂因素的可能。 结论:配对的单细胞多组学与长读长基因分型揭示,CH 突变驱动异常的 CD4+ T 细胞增殖并促进 HIV 持续存在,凸显了一种即使在抑制性抗逆转录病毒治疗下仍升高癌症风险的病毒-宿主相互作用。
查看英文原文 English abstract
Introduction: Clonal hematopoiesis (CH) is a precursor for acute myeloid leukemia (AML) and predictor of the development of hematologic cancers. Despite suppressive antiretroviral therapy, people living with HIV (PLWH) have higher incidence of clonal hematopoiesis, particularly mutations in DNMT3A . While DNMT3A mutations increase inflammation in myeloid cells and increase CD8+ T cell proliferation, the role of DNMT3A mutations in CD4+ T cells remain elusive. Given that CD4+ T cells are the major HIV reservoir, we postulate that HIV-induced systemic inflammation increases DNMT3A mutation, accelerates CD4+ T cell proliferation, and thus promotes HIV persistence in CD4+ T cells. Methods: To examine the impact of DNMT3A on CD4+ T cell proliferation, we spiked in HIV- and DNMT3A-specific primers in single-cell ECCITE-seq (GoT-seq) and paired HIV- and DNMT3A-targeted long-read sequencing (MAS-ISO-Seq) on peripheral blood CD4+ T cells from four strata (HIV+CH+, HIV+CH-, HIV-CH+, and HIV-CH-). We simultaneously captured HIV RNA, cellular transcriptome, surface proteins, T cell clonality, and DNMT3A mutations in the same single cell. Results: After QC, we captured 420,837 CD4+ T cells from 27 participants (7 HIV+CH+, 7 HIV+CH-, 5 HIV-CH+, and 8 HIV-CH-). Short-read scRNA-seq detected DNMT3A RNA in 32,554 cells (10.3%), while Long-read sequencing captured DNMT3A in 19,898 cells (8.6%), reflecting low DNMT3A expression levels in peripheral blood CD4+ T cells. Importantly, we overcame the 5' sequencing bias of short-read sequencing and captured 767 cells carrying single nucleotide polymorphisms (SNPs) within the DNMT3A. For HIV, short reads identified 170 RNA+ cells (0.055%), whereas long reads detected 3,842 HIV-infected cells, representing a 22-fold increase in sensitivity, and resolved 98 intact proviruses. TCR analysis reconstructed 22,648 unique T cell clones from 76,819 cells having mapped CDR3 region. Larger CD4+ T cell clones were enriched in cytotoxic CD4+ T cells expressing high GZMB/GZMH. Notably, we identified 100 HIV-infected cells (58.8%) in T cell clones. Clone sizes were greater in CD4+ T cells from HIV- CH+ than HIV-CH- donors, consistent with CH-driven T cell proliferation. Importantly, CD4+ T cells from HIV+ CH+ patients exhibited significantly greater clonal expansion and larger clones than those from HIV+CH- patients, suggesting CH mutations also promotes the proliferation of HIV-infected cells. Of note, age distributions did not differ across groups, which excluded age as a confounder for clonal expansion. Conclusion : Paired single-cell multi-omics with long-read genotyping reveal CH mutations drive the aberrant CD4+ T cell proliferation and promote HIV persistence, highlighting virus-host interaction that elevates cancer risk despite suppressive antiretroviral therapy.
利益披露 Disclosure
H. Ma, None.. T. Chen, None.. A. Jha, None.. J. M. Kwan, None.. I. Sereti, None.. Y. Ho, None.

← 返回 AACR 2026 检索